Some studies have also focused on the oncogenic role of miR-155 in the pathogenesis of B-cell lymphoma, including the targeting of NIAM, histone deacetylase 4 (HDAC4), SHIP1, and PIK3R1 (p85α) (53–56). Here, HDAC4 is linked to B-cell non-Hodgkin lymphoma.